Suchen und filtern

Gefundene Studien

PROCAPP A randomized, open-label phase III trial of mapisal versus urea hand-foot cream as prophylaxis for capecitabine-induced hand-foot syndrome in patients with gastrointestinal tumors or breast cancer AIO-LQ-0111 · Studie beendet Studie anzeigen

PROTECTOR Pre-Operative Treatment in rEseCTable cOlon cancer (PROTECTOR)
Prospective, randomized, open, multicenter Phase III trial to investigate the efficacy preoperative system therapy in advanced colon cancer AIO-KRK-0620 · In Vorbereitung Studie anzeigen

NEOBRAF Neoadjuvant encorafenib, binimetinib and cetuximab for patients with BRAF mutated/pMMR localized colorectal cancer - AIO Phase II trial AIO-KRK-0420 · Studie beendet Studie anzeigen

CIRCULATE Circulating tumor DNA based decision for adjuvant treatment in colon cancer stage II evaluation AIO-KRK-0217 · In Rekrutierung Studie anzeigen

NEOBIL Neoadjuvant bintrafusp alfa in patients with resectable biliary tract cancer AIO-HEP-0120 · Rekrutierung beendet Studie anzeigen

Re-Check Randomized phase II, open-label efficacy and safety study of second-line durvalumab plus tremelimumab versus platinum-based chemotherapy alone in patients with NSCLC and first-line checkpoint-inhibitor therapy followed by 2 cycles of platinum-based chemotherapy AIO-TRK-0221 · Studie beendet Studie anzeigen

PHERFLOT Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma - A phase II trial of the AIO study group AIO-STO-0321 · Rekrutierung beendet Studie anzeigen

INTEGRATE IIb Randomized Phase III Controlled Trials of Regorafenib containing regimens versus standard care in Refractory Advanced Gastro-Oesophageal Cancer (AGOC) - INTEGRATE IIb AIO-STO-0221/ass · Rekrutierung beendet Studie anzeigen

POLESTAR Phase IIA trial of short-term chemotherapy and pembrolizumab, followed by Pembrolizumab and OLaparib as firstline therapy in Her-2 negative gastric/gastroESophageal-juncTion (GEJ) AdenocaRcinoma AIO-STO-0121/ass · Rekrutierung beendet Studie anzeigen

METAPANC Intensivierte Therapie bei Patienten mit lokal resekta- blem oligometastatischen Pankreaskarzinom – multimodale operative Therapie versus alleinige systemische Chemotherapie. AIO-PAK-0219 · In Rekrutierung Studie anzeigen